THEME
Effective antibiotics are a cornerstone of basic and specialized medicine. The emergence of resistance in bacteria to antibiotics is slowly dismantling our ability to treat infections, alleviate human suffering, and save lives. The COVID-19 pandemic is a clear reminder of the deadly consequences the world faces, when we do not have the right treatments or vaccines available when needed.
ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.
Celebration!
This year ReAct is celebrating 15 years of action on antibiotic resistance. The story of ReAct started 15 years ago with a small group of people, many who are still with the network today. Here you find articles, a newly published report and webinar that we have produced to celebrate our 15 years of action on antibiotic resistance.
Theme
The rapid spread of antibiotic resistance around the world has evoked calls at the highest levels of the United Nations and its member governments to urgently adopt measures to tackle the growing problem. While these and other global and national policy initiatives are highly welcome and much needed, the world cannot afford to solely wait for them to be translated into action and change on the ground.
The top-down approach needs to be complemented with action and mobilization on grass-root level since the emergence and spread of antibiotic resistance is tightly linked to the practices and behaviors of individuals.
Welcome to subscribe
ReAct Newsletter – something for you?
Next one coming out end January.
Welcome to read a few previous ones and subscribe!
Policy news
On 29 November to 1 December, the World Health Organization held a virtual Special Session of the World Health Assembly. This to discuss the establishment of a new legal instrument – often referred to as a “pandemic treaty”. Purpose is to address some of the many shortfalls in global pandemic preparedness and response that has been exposed during COVID-19 pandemic. A key priority for ReAct is to have antibiotic resistance included in the scope of a new global agreement – fortunately a handful of countries highlighted exactly that.
News
ReAct Africa and South Centre hosted the 6th Annual Conference from 30 November to 3 December 2021 under the theme; ‘Progress achieved on the Global Action Plan on Antimicrobial Resistance and pandemic preparedness in the African Region’. The 4-day conference was the 2nd virtual conference that brought participation for 47 countries worldwide. Here you can find the 3 objectives for the conference, key takeaways and way forward.
Theme
ReAct articles relating to COVID-19 and antibiotic resistance.
The ReAct Toolbox is a user-friendly web-based resource that provides inspiration and guidance to take action and develop national action plans on antibiotic resistance. It is built on what has been done in the past in a variety of settings, and is aligned with ongoing and current initiatives from across the globe.
In the last 70 years the use of antibiotics has been crucial in improving countless lives and drastically reducing deaths caused by bacterial infections. The increasing development of antibiotic resistance is posing a serious threat to human health and development, the environment and for animal health. Learn more about ReAct’s work on antibiotic resistance here.
ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.
Involved in developing and implementing your country's National Action Plan on AMR? Here you find support tools and inspiration.
Engagement from civil society organizations and communities is needed to tackle antibiotic resistance. Learn more about how to get involved.
Globally coordinated governance on antimicrobial resistance - to ensures a sustainable response that takes into account the conditions for LMICs
A public health driven and end-to-end approach to innovation that enables sustainable access to effective antibiotics in LMICs